Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease-Reference-Cited by-同舟云学术

Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease

Published:2021 Issue:3 Volume:22 Page:755
ISSN:2153-8174
Container-title:Reviews in Cardiovascular Medicine
language:en
Short-container-title:Reviews in Cardiovascular Medicine

Author:

Galiero Raffaele,Caturano Alfredo,Vetrano Erica,Cesaro Arturo,Rinaldi Luca,Salvatore Teresa,Marfella Raffaele,Sardu Celestino,Moscarella Elisabetta,Gragnano Felice,Calabrò Paolo,Sasso Ferdinando Carlo

Publisher

IMR Press

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453070916-1265297445.pdf

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin–Heart Axis: Bridging Physiology to Insulin Resistance;International Journal of Molecular Sciences;2024-07-31

2. Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions;Nutrients;2024-07-11

3. Association between metabolic dysfunction-associated steatotic liver disease and risk of urolithiasis: an updated systematic review and meta-analysis;Internal and Emergency Medicine;2024-07-11

4. Impaired GK-GKRP interaction rather than direct GK activation worsens lipid profiles and contributes to long-term complications: a Mendelian randomization study;Cardiovascular Diabetology;2024-06-29

5. Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets;Pharmaceuticals;2024-06-14